TECH · Bio-Techne

Life-science reagents and diagnostics-tools maker

Risiko 4/10 · MODERATE RISK · pending buyout · $72.43 ▼ 0.03%🤖Von KI geschrieben

Stand der Zahlen: 07.09.2026 · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

• Price $72.43
• Market cap $11.4B
• P/E (ttm) 62.44
• Div yield 0.44%
• 52-wk range $43.20 – $72.62
• Index rank #488 / —

Wichtigste Risiken

• Deal breaks and the stock reverts to standalone value (Shareholders) — HIGH
• Antitrust review drags out the timeline (Shareholders) — MED
• Standalone growth has stalled if it must go it alone (Shareholders) — MED
• Biotech funding slump saps reagent demand (Customers) — MED

Fazit

An arbitrage position now, not a tools investment — upside is capped at the deal price and the spread is the whole game.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.